5.00 (0.73%) Aarti Pharmalabs has informed that it enclosed the Transcript of Earnings Conference Call held on February 10, 2026 on the Un-Audited Financial Results of the Company for the third quarter and nine months ended for the FY26.
The above information is a part of company’s filings submitted to BSE.